ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 160 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $947,000 | -88.0% | 33,000 | -91.8% | 0.28% | -83.0% |
| Q2 2017 | $7,880,000 | +25.1% | 400,000 | +33.3% | 1.64% | +39.5% |
| Q1 2017 | $6,300,000 | +1575.5% | 300,000 | +1400.0% | 1.17% | +1204.4% |
| Q4 2016 | $376,000 | -92.8% | 20,000 | -92.0% | 0.09% | -89.4% |
| Q3 2016 | $5,220,000 | -37.0% | 250,000 | -23.1% | 0.85% | -64.6% |
| Q2 2016 | $8,289,000 | +93.8% | 325,000 | +225.0% | 2.39% | +36.6% |
| Q4 2015 | $4,278,000 | +61.4% | 100,000 | 0.0% | 1.75% | +46.9% |
| Q3 2015 | $2,651,000 | – | 100,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |